✦ LIBER ✦

To Give or Not to Give Anti–Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies to Patients With KRAS G13D Mutation in Advanced Colorectal Cancer

✍ Scribed by Richard Kim; Timothy Kubal

Book ID: 116365647
Publisher: CIG Media Group, LP.
Year: 2012
Tongue: English
Weight: 165 KB
Volume: 11
Category: Article
ISSN: 1533-0028
DOI: 10.1016/j.clcc.2011.10.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

KRAS p.G13D mutations are associated wit

KRAS p.G13D mutations are associated with sensitivity to anti-EGFR antibody treatment in colorectal cancer cell lines

✍ Isabelle Messner, Giuseppe Cadeddu, Wolfgang Huckenbeck, Helen J. Knowles, Helmu 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 456 KB

American Society of Clinical Oncology Pr

American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy

✍ Allegra, C. J.; Jessup, J. M.; Somerfield, M. R.; Hamilton, S. R.; Hammond, E. H 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 87 KB

A phase I pharmacokinetic (PK) and seria

A phase I pharmacokinetic (PK) and serial tumor and skin pharmacodynamic (PD) study of weekly, every 2 weeks or every 3 weeks 1-hour (h) infusion EMD72000, an humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients (p) with advanced tumors known to overexpress the EGFR

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 256 KB

9118 POSTER Prospective Assesment of Com

9118 POSTER Prospective Assesment of Combined Pemetrexed and Erlotinib or Gefitinib Therapy After the Relapse to Erlotinib or Gefitinib in Patients With Advanced Non-Small Cell Lung Cancer Having an Active Epidermal Growth Factor Receptor Mutation

✍ Okishio, K.; Yoshimura, N.; Kimura, T.; Daga, H.; Takeda, K.; Kawaguchi, T.; Kob 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 55 KB

9017 POSTER DISCUSSION Initial Detection

9017 POSTER DISCUSSION Initial Detection of the Double Epidermal Growth Factor Receptor (EGFR) Mutation (L858R or Deletion in Exon 19 [del 19] Plus T790M) in Non-Small-Cell Lung Cancer (NSCLC) Patients (p) With Brain Metastases (mets) and the Influence of First-Line Chemotherapy on Outcome to Erlotinib

✍ Rolfo, C.; Moran, T.; Sanchez, J.; Molina-Vila, M.; Bertran-Alamilllo, J.; Camps 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB